---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294397918.md"
description: "During Thursday's intraday session, several healthcare stocks experienced significant volatility. Top gainers included Nuwellis (up 123.7%), GlucoTrack (up 79.85%), and Pulmonx (up 32.07%). Conversely, major losers featured Capricor Therapeutics (down 40.3%), Inovio Pharmaceuticals (down 37.5%), and Alnylam Pharmaceuticals (down 29.69%). Many of these movements coincided with the release of Q2 earnings reports."
datetime: "2026-07-30T17:05:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294397918.md)
  - [en](https://longbridge.com/en/news/294397918.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294397918.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Nuwellis** (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session.
-   **GlucoTrack** (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap stands at $1.8 million.
-   **Pulmonx** (NASDAQ:LUNG) shares moved upwards by 32.07% to $1.65. The company's market cap stands at $52.7 million. The company's, Q2 earnings came out yesterday.
-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) stock increased by 29.23% to $0.07. The market value of their outstanding shares is at $2.0 million.
-   **Corcept Therapeutics** (NASDAQ:CORT) shares moved upwards by 27.53% to $118.55. The company's market cap stands at $9.9 billion. As per the news, the Q2 earnings report came out yesterday.
-   **Bausch Health Companies** (NYSE:BHC) stock rose 26.28% to $5.91. The market value of their outstanding shares is at $1.7 billion. The company's, Q2 earnings came out yesterday.

### Losers

-   **Capricor Therapeutics** (NASDAQ:CAPR) shares decreased by 40.3% to $3.92 during Thursday's regular session.
-   **Inovio Pharmaceuticals** (NASDAQ:INO) stock decreased by 37.5% to $0.65. The company's market cap stands at $85.5 million.
-   **Alnylam Pharmaceuticals** (NASDAQ:ALNY) stock decreased by 29.69% to $201.53. The market value of their outstanding shares is at $38.2 billion. As per the press release, Q2 earnings came out today.
-   **Teladoc Health** (NYSE:TDOC) shares fell 27.1% to $6.69. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q2 earnings report came out yesterday.
-   **Autonomix Medical** (NASDAQ:AMIX) shares fell 23.75% to $3.48. The company's market cap stands at $2.4 million.
-   **Healthcare Triangle** (NASDAQ:HCTI) shares declined by 22.44% to $1.21. The market value of their outstanding shares is at $3.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [INO.US](https://longbridge.com/en/quote/INO.US.md)
- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)
- [NUWE.US](https://longbridge.com/en/quote/NUWE.US.md)
- [CAPR.US](https://longbridge.com/en/quote/CAPR.US.md)
- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)
- [LUNG.US](https://longbridge.com/en/quote/LUNG.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [CORT.US](https://longbridge.com/en/quote/CORT.US.md)
- [BHC.US](https://longbridge.com/en/quote/BHC.US.md)
- [TDOC.US](https://longbridge.com/en/quote/TDOC.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [HCTI.US](https://longbridge.com/en/quote/HCTI.US.md)

## Related News & Research

- [Alnylam Maintained at Buy as Analyst Reaffirms $346 Price Target on TTR Franchise Strength and Amvuttra Growth Visibility](https://longbridge.com/en/news/297493563.md)
- [GlucoTrack amends 8-K to add accountant review report for Lokahi interim financials](https://longbridge.com/en/news/297366213.md)
- [09:01 ETHealthcare Is Moving Into the Home. Home Accessibility Now Has a Validated Score.](https://longbridge.com/en/news/297656740.md)
- [TPG’s Asia OneHealthcare said to confidentially file for US$2.5 billion IPO](https://longbridge.com/en/news/297874967.md)
- [Alnylam announces new data at ESC Congress on AMVUTTRA](https://longbridge.com/en/news/297453980.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**